Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.

28/03/2024
/ Publications
/
IMPT
IMRT
Toxicity

This study reported the incidence of lymphopenia in 271 stage III NSCLC patients treated with IMPT (n=71) vs IMRT (n=200) and concurrent chemotherapy. The...

Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.

06/05/2024
/ Publications
/
Survival
Quality of life
Toxicity

This study from Japan reported clinical outcomes of 43 patient with operable stage IA or IB NSCLC treated with a dose of 66 GyRBE in 10 fractions for peripheral...

Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.

06/05/2024
/ Publications
/
Toxicity

This study by the Samsung group, Korea, reported clinical outcomes of 27 patients with inoperable early stage NSCLC treated by protons to a total dose of 64...

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.

06/05/2024
/ Publications
/
FLASH Therapy

This is a trial protocol of FAST-02. This trial includes 10 patients with 1-3 painful bone metastases in the thorax, excluding bone metastases in the spine...

A bibliometric analysis of cardiotoxicity in cancer radiotherapy.

06/05/2024
/ Publications
/
Quality of life
Survival

Radiation induced heart disease (RIHD) significantly impacts the long-term survival and quality of life of cancer survivors as one of the most devastating...

Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives.

14/02/2021
/ Publications
/
Reirradiation

This review examines the evolving role of PBT in the treatment of thoracic malignancies and evaluates the data supporting its use. Clinical outcomes data of PBT...

Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer.

14/03/2021
/ Publications
/
Toxicity

This study retrospectively reviewed 53 patients who received salvage PBT for locoregionally recurrent NSCLC. With a median follow-up time of 15.0 months, 26...

Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations.

14/02/2021
/ Publications

A review article examined data available of proton radiation for early-stage, advanced-stage and recurrent NSCLC, as well as protons in post-operative...

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.

14/09/2021
/ Publications
/
IMRT
Toxicity

This study retrospectively evaluated 136 postoperative radiotherapy (PORT) patients (61 PBT, 75 IMRT). Median OS was 76 and 46 months for PBT and IMRT with...

Long-term outcomes of high-dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall-cell lung cancer.

14/05/2021
/ Publications
/
Dosimetry
Toxicity

This study reported outcomes of 45 patients with stage III NSCLC treated with PBT of 74 GyE and concurrent chemotherapy. With a median follow-up time of 42.1...